Towards Healthcare

MicroRNA Sponge Service Companies, Investments and Market Forecast 2026-2035

Date : 13 February 2026

Key Players' Offerings in the Global MicroRNA Sponge Service Market with Recent Developments

Global MicroRNA Sponge Service Market Key Players

Company Offerings

Company Description
Thermo Fisher Scientific Inc. This majorly offers tools to assist in the design, delivery, and validation of miRNA sponges.
QIAGEN N.V. Its portfolio emphasizes the functional analysis, quantification, and detection of microRNAs.
GenScript Biotech Corporation This company mainly facilitates comprehensive molecular biology and custom RNA synthesis services.
System Biosciences (SBI) It has unveiled custom anti-miRNA services using their miRZip technology.
AcceGen Biotech A firm provides high-quality service for the construction of miRNA sponge vector clones.
GeneCopoeia, Inc. Its offering includes a set of microRNA (miRNA) inhibition solutions.
Abcam plc (Danaher) This explores tools and infrastructure to encourage microRNA research through other solutions.
Merck KGaA (Sigma-Aldrich) A company usually provides a complete suite of tools for microRNA (miRNA) research, like solutions for miRNA silencing and inhibition.
Horizon Discovery (Revvity) This offers inhibiting or silencing miRNA function through the Dharmacon brand.
Takara Bio Inc. It facilitates many related products and services for miRNA research, such as tools for extraction, quantification, and expression.

Market Growth

The global microRNA sponge service market size was estimated at USD 150.12 million in 2025 and is predicted to increase from USD 183.06 million in 2026 to approximately USD 1091.19 million by 2035, expanding at a CAGR of 21.94% from 2026 to 2035.

MicroRNA Sponge Service Market Trends and Growth (2026)

What are the Key Developments in the Global MicroRNA Sponge Service Market?

  • In October 2025, PrecisionRNA Biotech Pvt Ltd (Prerna) launched Cantel, a microRNA-based blood test for breast cancer screening.
  • In September 2025, WuXi Biologics unveiled TrueSite TI, an industry-leading targeted integration (TI)-based CHO cell line platform.

Ready to see the full mRNA MicroRNA Sponge Service Market picture under one place? - Explore the Dashboard Now

WhatsApp